Cited by 117Smoking Behavior and CessationGlobal Cancer Incidence and ScreeningLung Cancer Diagnosis and Treatment

A snapshot of smokers after lung and colorectal cancer diagnosis

Open access
Park, Elyse R., Japuntich, Sandra J., Rigotti, Nancy A., Traeger, Lara, He, Yulei, Wallace, Robert B., Malin, Jennifer L., Zallen, Jennifer P. +1 more·2012·Cancer

Abstract

BACKGROUND: Continued smoking after a cancer diagnosis may adversely affect treatment effectiveness, subsequent cancer risk, and survival. The prevalence of continued smoking after cancer diagnosis is understudied. METHODS: In the multi‐regional Cancer Care Outcomes Research and Surveillance cohort (lung cancer [N = 2456], colorectal cancer [N = 3063]), the authors examined smoking rates at diagnosis and 5 months after diagnosis and also study factors associated with continued smoking. RESULTS: Overall, 90.2% of patients with lung cancer and 54.8% of patients with colorectal cancer reported ever smoking. At diagnosis, 38.7% of patients with lung cancer and 13.7% of patients with colorectal cancer were smoking; whereas, 5 months after diagnosis, 14.2% of patients with lung cancer and 9.0% of patients with colorectal cancer were smoking. Factors that were associated independently with continued smoking among patients with nonmetastatic lung cancer were coverage by Medicare, other public/unspecified insurance, not receiving chemotherapy, not undergoing surgery, prior cardiovascular disease, lower body mass index, lower emotional support, and higher daily ever‐smoking rates (all P < .05). Factors that were associated independently with continued smoking among patients with nonmetastatic colorectal cancer were male sex, high school education, being uninsured, not undergoing surgery, and higher daily ever‐smoking rates (all P < .05). CONCLUSIONS: After diagnosis, a substantial minority of patients with lung and colorectal cancers continued smoking. Patients with lung cancer had higher rates of smoking at diagnosis and after diagnosis; whereas patients with colorectal cancer were less likely to quit smoking after diagnosis. Factors that were associated with continued smoking differed between lung and colorectal cancer patients. Future smoking‐cessation efforts should examine differences by cancer type, particularly when comparing cancers for which smoking is a well established risk factor versus cancers for which it is not. Cancer 2012;118: 3153–64. © 2012 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.26545

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among US cancer patients at initial diagnosis, smoking prevalence ranges from 15% to 54%.

    “Cigarette smoking is highly prevalent among cancer patients in the United States (US), with 15% to 54% of cancer patients reporting smoking at the time of their initial cancer diagnosis.1–3”

    From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [1]

    The Smoking Rates section (page not specified) reports smoking around diagnosis in 38.7% of lung cancer patients and 13.7% of colorectal cancer patients, supporting substantial smoking prevalence in these groups. It does not establish a 15%–54% range for US cancer patients generally; its figure near 54% refers to ever smoking, not smoking at diagnosis. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 57 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Park, E. R., Japuntich, S. J., Rigotti, N. A., Traeger, L., He, Y., Wallace, R. B., Malin, J. L., Zallen, J. P., & Keating, N. L.
Affiliations
  • Massachusetts General Hospital (US)
  • Harvard University (US)
  • University of Iowa (US)
  • University of California, Los Angeles (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Park, Elyse R.
Venue
Cancer
Publisher
Wiley
Published
2012-01-23
Volume
118
Issue
12
Pages
3153-3164
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1493292049
Cited by
117
References
57
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 12 · 2017: 7 · 2016: 13 · 2015: 14 · 2014: 11 · 2013: 9 · 2012: 2
FWCI
7.72
Type
journal article
Language
en
Open access
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5u01ca093344-08)
  • National Cancer Institute (CRS 02-164, U01CA093339, U01CA093326, U01-CA093344, U01CA093348, U01CA093329, U01CA093332, U01CA093324)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
lung cancer, colorectal cancer, smoking prevalence, smoking cessation, insurance status, chemotherapy, cardiovascular disease, emotional support, body mass index, sex differences, educational attainment
MeSH terms
Aged, Female, Humans, Lung Neoplasms, Male, Middle Aged, Prospective Studies, Risk Factors, Smoking, Colorectal Neoplasms, Smoking Cessation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review